tiprankstipranks
Trending News
More News >
Armata Pharma’s inhaled AP-PA02 shows positive results in Phase 2 study
PremiumThe FlyArmata Pharma’s inhaled AP-PA02 shows positive results in Phase 2 study
4M ago
Armata Pharmaceuticals Announces CMO Departure Agreement
Premium
Company Announcements
Armata Pharmaceuticals Announces CMO Departure Agreement
5M ago
Armata Pharmaceuticals Extends Credit Agreement and CMO Departs
Premium
Company Announcements
Armata Pharmaceuticals Extends Credit Agreement and CMO Departs
6M ago
Armata Pharmaceuticals VP Richard Rychlik Departs with Benefits
PremiumCompany AnnouncementsArmata Pharmaceuticals VP Richard Rychlik Departs with Benefits
7M ago
Armata Pharmaceuticals Updates Progress and Corporate Presentation
Premium
Company Announcements
Armata Pharmaceuticals Updates Progress and Corporate Presentation
8M ago
Armata Pharmaceuticals Welcomes David House as New SVP of Finance
Premium
Company Announcements
Armata Pharmaceuticals Welcomes David House as New SVP of Finance
9M ago
Armata Pharmaceuticals Updates Chief Medical Officer’s Compensation
PremiumCompany AnnouncementsArmata Pharmaceuticals Updates Chief Medical Officer’s Compensation
9M ago
Armata Pharmaceuticals completes enrollment of Phase 2 study of AP-PA02
Premium
The Fly
Armata Pharmaceuticals completes enrollment of Phase 2 study of AP-PA02
10M ago
Armata Pharmaceuticals Under Pressure: Navigating the Risks as Cost-Cutting Measures Threaten Revenue
Premium
Company Announcements
Armata Pharmaceuticals Under Pressure: Navigating the Risks as Cost-Cutting Measures Threaten Revenue
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100